Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-004593
Filing Date
2013-03-07
Accepted
2013-03-07 18:29:24
Documents
1
Period of Report
2013-03-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3919
  Complete submission text file 0001179110-13-004593.txt   5098
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Vukovic Vojo (Reporting) CIK: 0001466794 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 13674790